Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.
about
Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitisResearch questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analysesEvaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sedimentsDiscordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence CountryPhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data.Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian FederationMolecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina FasoAllelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.The value of laboratory tests in the diagnosis of tuberculosisA 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting.Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance SettingsCanadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis.Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosisPCR-restriction fragment length polymorphism for rapid, low-cost identification of isoniazid-resistant Mycobacterium tuberculosisDetection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.Revisiting the susceptibility testing of Mycobacterium tuberculosis to ethionamide in solid culture medium.Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis.Discrepancies in Drug Susceptibility Test for Tuberculosis Patients Resulted from the Mixed Infection and the Testing SystemUse of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.Reliability of Mycobacterial Growth Indicator Tube (MGIT) 960 for the detection of isoniazid resistance in a tuberculosis endemic setting.Evaluation of the performance of the microscopic observation drug susceptibility assay for diagnosis of extrapulmonary tuberculosis in China: A preliminary study.Modification of proportion sensitivity testing method for ethionamide.Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.Rapid Microarray-based Detection of Rifampicin-, Isoniazid- and Fluoroquinolone Resistance in Mycobacterium tuberculosis using a Single Cartridge.Evaluation of the GenoType® MTBDRsl assay in Korean patients with MDR or XDR tuberculosis.Evaluation of the GenoType MTBDR and MTBDR for the detection of drug-resistant on isolates from Beijing, China
P2860
Q28471599-1B38B01F-AC92-4C02-8B6B-28110E8A5CA1Q28481610-23ACF44F-43BB-4413-AD51-97B3C0B8F2EEQ28485224-B8FD0778-9E53-4149-837A-5CC2DAE84F92Q28551469-B6E66F24-C2D6-4D21-B365-14B79C49D696Q30927278-92034FBB-E32C-4544-B92F-AE1329C98AE7Q33318449-0AE5A3C3-B808-4A54-A082-223D08463D99Q33417860-2D8107D6-C7EC-4E4E-9F1E-6B8A661A61CBQ33498127-11CB77AC-137C-4C96-9897-1180F0D8DD71Q33559021-621C411A-0624-4EC6-8149-405CC0B6EDA5Q33693330-FF7791BD-D3F1-4BF1-88E0-C7B6028B6E29Q34707937-7AE513E1-55A2-4010-BB8B-309F7E17CFE2Q35139804-3007CC15-EFD2-4C8C-9630-2E8BB97EE490Q35599028-7943DF9F-CB9C-4D29-80E5-678DCEB4AB5BQ35689060-6C6EB59B-B963-4F6D-957B-2552A416D026Q35690257-68D9964D-5D26-4768-A4BC-35110E540E33Q35913993-BB660A53-E4AF-4B2E-8707-D3F80A4ABE70Q35943005-31137268-F719-4C78-A4A1-F16B985D316FQ35947438-1ECE3EE9-644E-4F14-A2B6-FE98D6E285F3Q36550160-12AFF9DE-A44D-4A39-AE0E-B8567E2571EAQ37214096-DFB032F1-D848-4B6B-862F-8674976A5179Q37274766-A5730AFA-B723-48DF-80A4-80C39A8933F5Q40599116-905E4D09-8097-4E14-8A43-8BAA2F326CA1Q40727240-FDA72793-7E2A-4857-9EEC-3D299CF8F94DQ41072559-351187F8-0CD2-4B73-BDA8-7F40BEBD8F22Q42432121-ED115CF2-CDDE-44CF-8621-013AD8CBB537Q42708214-BDF64160-038E-4529-8902-E4591975A246Q45177575-636CBFEA-DB94-4C3B-90EE-5086A1813A37Q45186615-07399B3C-147A-4589-A6D1-24355F8F7B60Q47139099-FA4C3596-E0C3-4F3D-B1ED-EDAFE24FC0C8Q47355729-23291415-5DEC-4E62-BFEB-9647805F2C78Q51597252-FD849E80-DC7B-4E53-AF77-D9333A48100CQ57487055-B116B6E5-6B7B-4216-BFD2-9CDFBD2F27A9
P2860
Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Current perspectives on drug s ...... omated nonradiometric systems.
@ast
Current perspectives on drug s ...... omated nonradiometric systems.
@en
type
label
Current perspectives on drug s ...... omated nonradiometric systems.
@ast
Current perspectives on drug s ...... omated nonradiometric systems.
@en
prefLabel
Current perspectives on drug s ...... omated nonradiometric systems.
@ast
Current perspectives on drug s ...... omated nonradiometric systems.
@en
P2093
P2860
P1476
Current perspectives on drug s ...... omated nonradiometric systems.
@en
P2093
Armando Olivieri
Claudio Piersimoni
Claudio Scarparo
Luca Benacchio
P2860
P356
10.1128/JCM.44.1.20-28.2006
P407
P577
2006-01-01T00:00:00Z